The National Nuclear Security Administration is awarding NorthStar Medical Radioisotopes, LLC, with a second tranche of funding aimed at accelerating production of Molybdenum-99, a critical medical isotope. The NNSA said yesterday that it is providing $10.9 million…
SUBSCRIBER ACCESS
Thank you for visiting
Weapons Complex Morning Briefing!
You must be logged in as a subscriber to view this page.
